{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:47:17Z","timestamp":1777596437832,"version":"3.51.4"},"reference-count":38,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2022,9,30]]},"DOI":"10.7883\/yoken.jjid.2021.720","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:16:41Z","timestamp":1648678601000},"page":"445-453","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Accuracy of Human Immunodeficiency Virus In Vitro Assays Evaluated by the World Health Organization Prequalification Evaluation Laboratories: Systematic Review and Meta-Analysis"],"prefix":"10.7883","volume":"75","author":[{"given":"Santanu","family":"Banerjee","sequence":"first","affiliation":[{"name":"Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir","family":"Bhatta","sequence":"additional","affiliation":[{"name":"Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srijita","family":"Nandi","sequence":"additional","affiliation":[{"name":"Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[{"name":"Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malay Kumar","family":"Saha","sequence":"additional","affiliation":[{"name":"Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. Joint United Nations Programme on HIV\/AIDS (UNAIDS). Fast-Track: ending the AIDS epidemic by 2030. Available at &lt;https:\/\/in.one.un.org\/wp-content\/uploads\/2016\/09\/Fast_Tract_Ending_the_AIDS_Epidemic_2013.pdf&gt;. Accessed September 21,2021."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Urio LJ, Mohamed MA, Mghamba J, et al. Evaluation of HIV antigen\/antibody combination ELISAs for diagnosis of HIV infection in Dar Es Salaam, Tanzania. Pan Afr Med J. 2015;20:196.","DOI":"10.11604\/pamj.2015.20.196.4934"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gliddon HD, Peeling RW, Kamb ML, et al. A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis. Sex Transm Infect. 2017;93: S3-S15.","DOI":"10.1136\/sextrans-2016-053069"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kerr DL. HIV infection and AIDS in Africa and the Third World. J Sch Health. 1989;59:369-370.","DOI":"10.1111\/j.1746-1561.1989.tb04749.x"},{"key":"5","unstructured":"5. Centers for Disease Control and Prevention (CDC). Late versus early testing of HIV--16 sites, United States, 2000\u20132003. MMWR Morb Mortal Wkly Rep. 2003;52:581-586."},{"key":"6","unstructured":"6. World Health Organization (WHO). HIV assays: laboratory performance and other operational characteristics rapid diagnostic tests. Report 18 (Geneva, Switzerland). 2015. Available at &lt;https:\/\/www.who.int\/diagnostics_laboratory\/publications\/15032_hiv_assay_report18.pdf?ua=1&gt;. Accessed September 21,2021."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Feng X, Wang J, Gao Z, et al. An alternative strategy to western blot as a confirmatory diagnostic test for HIV Infection. J Clin Virol. 2017;88:8-11.","DOI":"10.1016\/j.jcv.2016.12.010"},{"key":"8","unstructured":"8. Food and Drug Administration (FDA). Issue Summary: reclassification of HIV point of care and laboratory-based serological and NAT diagnostic devices from Class III (PMA) to Class II 510(k). Available at &lt;https:\/\/www.fda.gov\/media\/114346\/download&gt;. Accessed September 21,2021."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Alexander TS. Human immunodeficiency virus diagnostic testing: 30 years of evolution. Clin Vaccine Immunol. 2016;23:249-253.","DOI":"10.1128\/CVI.00053-16"},{"key":"10","unstructured":"10. Centers for Disease Control and Prevention (CDC). Rapid HIV testing in outreach and other community settings \u2013 United States, 2004-2006. MMWR Morb Mortal Wkly Rep. 2007;56:1233-1237."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nandi S, Maity S, Bhunia SC, et al. Comparative assessment of commercial ELISA kits for detection of HIV in India. BMC Res Notes. 2014;7:436.","DOI":"10.1186\/1756-0500-7-436"},{"key":"12","unstructured":"12. World Health Organization (WHO). Guidelines for using HIV testing technologies in surveillance; selection, evaluation and implementation, 2009 Update. Available at &lt;https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK305270\/#_ncbi_dlg_citbx_NBK305270&gt;. Accessed September 21, 2021."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gray RH, Makumbi F, Serwadda D, et al. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ. 2007;335:188.","DOI":"10.1136\/bmj.39210.582801.BE"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bhatta M, Dutta N, Nandi S, et al. Mother-to-child HIV transmission and its correlates in India: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2020;20:509.","DOI":"10.1186\/s12884-020-03193-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Stengel D, Bauwens K, Sehouli J, et al. A likelihood ratio approach to meta-analysis of diagnostic studies. J Med Screen. 2003;10:47-51.","DOI":"10.1258\/096914103321610806"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lee J, Kim KW, Choi SH, et al. Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part II. Statistical methods of meta-analysis. Korean J Radiol. 2015;16:1188-1196.","DOI":"10.3348\/kjr.2015.16.6.1188"},{"key":"17","unstructured":"17. Macaskill P, Gatsonis C, Deeks J, et al. Cochrane handbook for systematic reviews of diagnostic test accuracy. Version 1.0. Available at &lt;methods.cochrane.org\/sites\/methods.cochrane.org.sdt\/files\/public\/uploads\/Chapter%2010%20-%20Version%201.0.pdf&gt;. Accessed September 21, 2021."},{"key":"18","unstructured":"18. Dwamena B. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. Available at &lt;https:\/\/ideas.repec.org\/c\/boc\/bocode\/s456880.html&gt;. Accessed September 21, 2021."},{"key":"19","unstructured":"19. Wang D, Mou ZY, Zhai JX, et al. Application of Stata software to test heterogeneity in meta-analysis method. Zhonghua Liu Xing Bing Xue Za Zhi. 2008;29:726\u2013729. Chinese."},{"key":"20","unstructured":"20. World Health Organization (WHO). WHO prequalification of in vivo diagnostics, Public report; Product: Product: MERISCREEN HIV 1-2 WB WHO reference number: PQDx 0464-074-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/PQDx_0464-074-00_MERISCREEN_HIV-1-2_WB_v2.0.pdf&gt;. Accessed July 28, 2022."},{"key":"21","unstructured":"21. World Health Organization (WHO). WHO prequalification of in vivo diagnostics, Public report; Product: STANDARD Q HIV 1\/2 Ab 3-Line Test: WHO reference number: PQDx 0383-117-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/PQDx_0383-117-00_STANDARD-Q-HIV-12-Ab3-LineTest_v1.pdf&gt;. Accessed July 28, 2022."},{"key":"22","unstructured":"22. World Health Organization (WHO). WHO prequalification of in vivo diagnostics, Public report; Product: First Response HIV 1-2.0 Card test (Version 2.0). WHO reference number: PQDx 0363-010-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/200312_amended_final_pqpr_pqdx_0363_010_00_first_response_hiv_test_0.pdf&gt;. Accessed July 28, 2022."},{"key":"23","unstructured":"23. World Health Organization (WHO). WHO prequalification of in vivo diagnostics, Public report; Product: ONE STEP Anti-HIV (1&amp;2) Test: WHO reference number: PQDx0372-017-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/200219_amended_pqpr_0372_017_00_one_step_anti_hiv_test_v2.pdf&gt;. Accessed July 28, 2022."},{"key":"24","unstructured":"24. World Health Organization (WHO). WHO prequalification of in vivo diagnostics, Public report; Product: DPP<sup>\u00ae<\/sup> HIV 1\/2 Assay: WHO reference number: PQDx 0053-006-00, Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/180130_final_amended_pqpr_0053_006_00_v3.pdf&gt;. Accessed July 28, 2022."},{"key":"25","unstructured":"25. World Health Organization (WHO). WHO prequalification of in vivo diagnostics, Public report; Product: OraQuick HIV 1\/2 Rapid Antibody Test: WHO reference number: PQDx 0159-055-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/200124_pqdx_0159_055_00_oraquick_hiv_final_pqpr.pdf&gt;. Accessed July 28, 2022."},{"key":"26","unstructured":"26. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: Rapid Test for Antibody to Human Immunodeficiency Virus (HIV) (Colloidal Gold Device): WHO reference number: PQDx 0005-005-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/PQDx_0005-005-00_ColloidalGoldDevice_v4.pdf&gt;. Accessed July 28, 2022."},{"key":"27","unstructured":"27. World Health Organization (WHO). WHO prequalification of in vitro diagnostics, Public report; Product: SURE CHECK HIV 1\/2 Assay: Number: PQDx 0054-006-00). Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/PQDx_0054-006-00_SURE-CHECK_HIV_1-2_Assay_v3.pdf&gt;. Accessed July 28, 2022."},{"key":"28","unstructured":"28. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: ABON HIV 1\/2\/O Tri-Line Human Immunodeficiency Virus Rapid Test Device: WHO reference number: PQDx 0141-051-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/190301_amended_pqpr_0141_051_00_v7.pdf&gt;. Accessed July 28, 2022."},{"key":"29","unstructured":"29. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: VIKIA HIV 1\/2 WHO reference number: PQDx 0150-016-00). Availabled at &lt;https:\/\/www.who.int\/diagnostics_laboratory\/evaluations\/131212_0150_016_00_public_report_final_v1.pdf?ua=1&gt; Accessed September 21, 2021 (Current URL is not available for this reference as its web-location has been moved or deleted by the WHO. A previously downloaded pdf file of the reference is available with the authors.)."},{"key":"30","unstructured":"30. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: INSTI HIV-1\/HIV-2 Antibody Test: Number: PQDx 0002-002-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/191111_amended_final_pqpr_0002_002_00_v5-rsize.pdf&gt;. Accessed July 28, 2022."},{"key":"31","unstructured":"31. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: Bioline HIV 1\/2 3.0: Number: PQDx 0027-012-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/PQDx_0027-012-00_BiolineHIV_1-2-3_v5.pdf&gt;. Accessed July 28, 2022."},{"key":"32","unstructured":"32. World Health Organization (WHO). WHO prequalification of in vitro diagnostics, Public report; Product: Uni-Gold HIV: WHO reference number: PQDx 0149-052-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/PQDx_0149-052-00-Uni-Gold_HIV_v11.pdf&gt;. Accessed July 28, 2022."},{"key":"33","unstructured":"33. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: HIV 1\/2 STAT-PAK<sup>\u00ae<\/sup>: Number: PQDx 0007-006-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/120116_0007_006_00_public_report_final_v1.pdf&gt;. Accessed July 28, 2022."},{"key":"34","unstructured":"34. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: Determine HIV-1\/2: Number: PQDx 0033-013-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/PQDx_0033-013-00_DetermineHIV-1-2v_7.pdf&gt;. Accessed July 28, 2022."},{"key":"35","unstructured":"35. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: HIV 1\/ 2 STAT-PAK<sup>\u00ae<\/sup>: Number: PQDx 0007-006-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/120116_0007_006_00_public_report_final_v1.pdf&gt;. Accessed July 28, 2022."},{"key":"36","unstructured":"36. World Health Organization (WHO). WHO prequalification of in vitro diagnostics, Public report; Product: m-PIMA HIV-1\/2 Detect: WHO reference number: PQDx 0226-032-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/PQDx_0226-032-00_m-PIMA-HIV12-Detect_v6.pdf&gt;. Accessed July 28, 2022."},{"key":"37","unstructured":"37. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: COBAS<sup>\u00ae<\/sup> AmpliPrep\/COBAS<sup>\u00ae<\/sup> TaqMan<sup>\u00ae<\/sup> HIV-1 Qualitative Test, version 2.0 (TaqMan 96): WHO reference number: PQDx 0200-046- 00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/160530_amended_final_public_report_pqdx_0200_046_00_taqman96.pdf&gt;. Accessed July 28, 2022."},{"key":"38","unstructured":"38. World Health Organization (WHO). WHO prequalification of diagnostics programme, Public report; Product: MP Diagnostics HIV Blot 2.2: Number: PQDx 0198-071-00. Available at &lt;https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/160404_final_public_report_0198_071_00_v2.pdf&gt;. Accessed July 28, 2022."}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/5\/75_JJID.2021.720\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T04:53:28Z","timestamp":1663995208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/5\/75_JJID.2021.720\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2021.720","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"article-number":"JJID.2021.720"}}